ABEONA THERAPEUTICS INC
For the period ended Jun 30, 2024. Filed Aug 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2024 · Filed Aug 12, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Securities Trading Arrangements of Directors and Executive Officers
On April 25, 2024, Vishwas Seshadri, the Company’s President and Chief Executive Officer and a member of the Company’s board of directors, terminated a Rule 10b5-1 trading arrangement. On April 25, 2024, Joseph Vazzano, the Company’s Chief Financial Officer, terminated two Rule 10b5-1 trading arrangements. Each of the terminated trading arrangements were intended to satisfy the affirmative defense in Rule 10b5-1(c).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.